Jeff Sternlicht: Inflammation is The ‘Storm’ Before Atherosclerosis
Jeff Sternlicht, Emergency Physician and Medical Director at Vituity, shared a post on LinkedIn:
“Atherosclerosis is not just a cholesterol problem. It’s also an inflammation problem.
We’ve gotten very good at measuring and treating LDL and Аров.
And that matters.
But there’s another layer of risk that often goes unmeasured.
Inflammation.
hsCRP is a simple blood test that can detect that ‘storm’ long before symptoms, long before an event.
Levels above ~2 mg/L should make us pause and look deeper.
What’s becoming more clear is that even when LDL and ApoB are well controlled, residual inflammatory risk can persist.
This hasn’t always been part of routine screening, but it’s now being recognized more explicitly in newer guidelines.
In my own case, this was a major blind spot.
Lowering ApoB mattered.
But addressing inflammation changed my trajectory.
If we’re not measuring inflammation, we’re not seeing the full picture of risk.
Disclaimer:
Views are my own and not those of my employer or affiliates.
This is for educational purposes only and not medical advice.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda